Comparison of Pericapsular Nerve Group Block and Quadratus Lumborum Block

Not Applicable

Completed

• Conditions: Pericapsular Nerve; Quadratus Lumborum; Total Hip Surgery
• Interventions: Drug: PENG/LFCN and QL Blocks

• Registration Number: NCT05654519
• Lead Sponsor: Konya Necmettin Erbakan Üniversitesi

Brief Summary

Adequate pain management following total hip arthroplasty (THA) is a key component for patient satisfaction and early ambulation. However, due to the complexity of the innervation of the hip joint, the most appropriate anaesthetic and analgesic technique for THA remains unclear. A femoral nerve block is commonly performed and well established but is associated with motor weakness. Recently, the pericapsular nerve group (PENG) block has been introduced as an effective choice which targets the articular branches of the hip. The quadratus lumborum block (QLB) is a relatively new regional block that has been reported to provide effective analgesia for THA.

The main objective of this study is to compare the effectiveness of the ultrasound-guided PENG block technique compared to QLB block in terms of efficacy of pain control and the safety profile after total hip arthroplasty under spinal anesthesia.

Detailed Description

The patients will be randomly classified into two equal groups (40 patients each). Group allocation will be done by computer generated random numbers and closed opaque sealed envelopes. The study will be designed to be double blind as all patients and outcomes assessor will be blinded to group assignment.

Patients will be randomized to one of three equal groups:

Group I (n= 40 patients): Patients in this group will receive an ipsilateral single shot of QLB (30 ml of plain bupivacaine 0.25%) after surgery using ultrasonographic guidance.

Group II(n= 40 patients): patients in this group will receive an ipsilateral single-shot of PENG block (25 ml of plain bupivacaine 0.25%) and LFCN block (5 ml of plain bupivacaine 0.25%) after surgery using ultrasonographic guidance.

Study Timeline

• Study Start: 2022-01-01
• Study First Submitted: 2022-11-30
• Study First Submitted QC: 2022-12-08
• Study First Posted: 2022-12-16
• Status Verified: 2023-04
• Primary Completion: 2023-04-10
• Study Completion: 2023-04-21
• Last Update Submitted: 2024-12-17
• Last Update Posted: 2024-12-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Physical status according to American Society of Anesthesiologists (ASA ) I-III

Exclusion Criteria

• Younger than 40 years old and older than 85
• Patients undergoing general anesthesia
• Allergy or intolerance to one of the study medications
• Infection of the skin at the site of the needle puncture,
• Patients who do not accept the procedure
• History of bleeding diathesis
• ASA IV,
• Chronic gabapentin/pregabalin,opioid use
• Hepatic or renal insufficiency
• Previous operation on the same hip
• BMI >40

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group QL Block	PENG/LFCN and QL Blocks	A convex transducer will be placed in the transverse plane on the flank cranial to the iliac crest to visualise the transverse process of the 4th lumbar vertebra, erector spina, quadratus lumborum and psoas muscles as a 'Shamrock sign'. The needle will inserted in to the fascial plane between the quadratus lumborum and psoas muscles and 30 ml bupivacaine 0.25% will be administered.
Group PENG+LFCN Block	PENG/LFCN and QL Blocks	A linear probe will be placed on the anterior inferior iliac crest in the transverse plane while the patient is in the supine position. After rotating 45 degrees, the pubic ramus, femoral artery and psoas muscle will be visualized. Puncture will be performed in a lateromedial direction until the needle tip reached the plane between the iliopsoas tendon and the iliopubic eminence After a negative aspiration test, 25 ml bupivacaine 0.25% will be injected. Then, the lateral femoral cutaneous nerve (LFCN) block was performed using linear US probe (10-18 MHz).The LFCN will be localized, infero-medially to the antero-superior iliac spine, laterally to the sartorius muscle and 5 ml of bupivacaine 0.25% will be carefully injected.

Primary Outcome Measures

Name	Time	Method
Pain scores	Changes from baseline opioid consumption at postoperative 0, 2, 6, 12 and 24 hours	Numerical Rating Scale-NRS (0 = no pain and 10 = worst imaginable painranged from 0 to 10)
Opioid consumption	Changes from baseline opioid consumption at postoperative 0, 2, 6, 12 and 24 hours	Mean opioid consumption in morphine equivalents

Secondary Outcome Measures

Name	Time	Method
Presence of postoperative nausea, vomiting, pruritus, urinary retention, respiratory depression	Postoperative 24 hours period	Presence of postoperative nausea, vomiting, pruritus, urinary retention, respiratory depressio
Patient satisfaction	Postoperative 24 hours period	Patients asked whether they would choose the same anaesthetic management in a future operation: Yes/No
Quadriceps muscle strength	Postoperative 24 hours period	Quadriceps motor function will be tested with the patient supine and with the hip and knee flexed at 45º and 90º, respectively

Trial Locations

Locations (1)

Alper KILICASLAN; 🇹🇷 Konya, Turkey